114 related articles for article (PubMed ID: 12498269)
1. Determination of free and liposome-associated daunorubicin and daunorubicinol in plasma by capillary electrophoresis.
Griese N; Blaschke G; Boos J; Hempel G
J Chromatogr A; 2002 Dec; 979(1-2):379-88. PubMed ID: 12498269
[TBL] [Abstract][Full Text] [Related]
2. Quantification of daunorubicin and daunorubicinol in plasma by capillary electrophoresis.
Hempel G; Schulze-Westhoff P; Flege S; Boos J
J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(2):221-8. PubMed ID: 11486832
[TBL] [Abstract][Full Text] [Related]
3. Determination of idarubicin and idarubicinol in plasma by capillary electrophoresis.
Hempel G; Haberland S; Schulze-Westhoff P; Möhling N; Blaschke G; Boos J
J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):287-92. PubMed ID: 9367219
[TBL] [Abstract][Full Text] [Related]
4. Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome.
Bellott R; Pouna P; Robert J
J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(2):257-67. PubMed ID: 11417870
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia.
Bellott R; Auvrignon A; Leblanc T; Pérel Y; Gandemer V; Bertrand Y; Méchinaud F; Bellenger P; Vernois J; Leverger G; Baruchel A; Robert J
Cancer Chemother Pharmacol; 2001; 47(1):15-21. PubMed ID: 11221955
[TBL] [Abstract][Full Text] [Related]
6. Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin.
Zucchetti M; Boiardi A; Silvani A; Parisi I; Piccolrovazzi S; D'Incalci M
Cancer Chemother Pharmacol; 1999; 44(2):173-6. PubMed ID: 10412954
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma.
Fumagalli L; Zucchetti M; Parisi I; Viganò MG; Zecca B; Careddu A; D'Incalci M; Lazzarin A
Cancer Chemother Pharmacol; 2000; 45(6):495-501. PubMed ID: 10854138
[TBL] [Abstract][Full Text] [Related]
8. Anthracycline analysis by capillary electrophoresis. Application to the analysis of daunorubicine in Kaposi sarcoma tumor.
Siméon N; Chatelut E; Canal P; Nertz M; Couderc F
J Chromatogr A; 1999 Aug; 853(1-2):449-54. PubMed ID: 10486752
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of doxorubicin, daunorubicin, and idarubicin by capillary electrophoresis with laser-induced fluorescence detection.
Pérez-Ruiz T; Martínez-Lozano C; Sanz A; Bravo E
Electrophoresis; 2001 Jan; 22(1):134-8. PubMed ID: 11197162
[TBL] [Abstract][Full Text] [Related]
10. Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia.
Pea F; Russo D; Michieli M; Baraldo M; Ermacora A; Damiani D; Baccarani M; Furlanut M
Cancer Chemother Pharmacol; 2000; 46(4):279-86. PubMed ID: 11052625
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring of doxorubicin in paediatric oncology using capillary electrophoresis.
Hempel G; Schulze-Westhoff P; Flege S; Laubrock N; Boos J
Electrophoresis; 1998 Nov; 19(16-17):2939-43. PubMed ID: 9870393
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients.
Eksborg S; Ehrsson H; Andersson B; Beran M
J Chromatogr; 1978 Jun; 153(1):211-8. PubMed ID: 659557
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of liposomal daunorubicin in children.
Hempel G; Reinhardt D; Creutzig U; Boos J
Br J Clin Pharmacol; 2003 Oct; 56(4):370-7. PubMed ID: 12968981
[TBL] [Abstract][Full Text] [Related]
14. Higher plasma but not intracellular concentrations after infusion with liposomal daunorubicin compared with conventional daunorubicin in adult acute myeloid leukemia.
Löfgren C; Lehmann S; Jönsson-Videsäter K; Möllgård L; Linder O; Tidefelt U; Hassan M; Paul C
Ther Drug Monit; 2007 Oct; 29(5):626-31. PubMed ID: 17898654
[TBL] [Abstract][Full Text] [Related]
15. Direct quantification of unencapsulated doxorubicin in liposomal doxorubicin formulations using capillary electrophoresis.
Ansar SM; Jiang W; Mudalige T
Int J Pharm; 2018 Oct; 549(1-2):109-114. PubMed ID: 29981410
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous analysis of liposomal doxorubicin and doxorubicin using capillary electrophoresis and laser induced fluorescence.
Kim HS; Wainer IW
J Pharm Biomed Anal; 2010 Jul; 52(3):372-6. PubMed ID: 19625153
[TBL] [Abstract][Full Text] [Related]
17. Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle-encapsulated and liposome-encapsulated doxorubicin formulations.
Wei G; Xiao S; Si D; Liu C
Biomed Chromatogr; 2008 Nov; 22(11):1252-8. PubMed ID: 18651589
[TBL] [Abstract][Full Text] [Related]
18. High concentration of Daunorubicin and Daunorubicinol in human malignant astrocytomas after systemic administration of liposomal Daunorubicin.
Albrecht KW; de Witt Hamer PC; Leenstra S; Bakker PJ; Beijnen JH; Troost D; Kaaijk P; Bosch AD
J Neurooncol; 2001 Jul; 53(3):267-71. PubMed ID: 11718259
[TBL] [Abstract][Full Text] [Related]
19. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques.
Mayer LD; St-Onge G
Anal Biochem; 1995 Dec; 232(2):149-57. PubMed ID: 8747469
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol.
Hempel G; Relling MV; de Rossi G; Stary J; De Lorenzo P; Valsecchi MG; Barisone E; Boos J; Pieters R
Pediatr Blood Cancer; 2010 Mar; 54(3):355-60. PubMed ID: 19731319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
